SNSE
Price
$0.34
Change
-$0.02 (-5.56%)
Updated
May 14, 04:48 PM (EDT)
Capitalization
8.57M
78 days until earnings call
VSTM
Price
$7.14
Change
-$0.32 (-4.29%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
367.12M
Ad is loading...

SNSE vs VSTM

Header iconSNSE vs VSTM Comparison
Open Charts SNSE vs VSTMBanner chart's image
Sensei Biotherapeutics
Price$0.34
Change-$0.02 (-5.56%)
Volume$130
Capitalization8.57M
Verastem
Price$7.14
Change-$0.32 (-4.29%)
Volume$19.34K
Capitalization367.12M
SNSE vs VSTM Comparison Chart
Loading...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNSE vs. VSTM commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNSE is a Hold and VSTM is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (SNSE: $0.36 vs. VSTM: $7.46)
Brand notoriety: SNSE and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNSE: 6% vs. VSTM: 244%
Market capitalization -- SNSE: $8.57M vs. VSTM: $367.12M
SNSE [@Biotechnology] is valued at $8.57M. VSTM’s [@Biotechnology] market capitalization is $367.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $289.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNSE’s FA Score shows that 1 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • SNSE’s FA Score: 1 green, 4 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, both SNSE and VSTM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNSE’s TA Score shows that 2 TA indicator(s) are bullish while VSTM’s TA Score has 6 bullish TA indicator(s).

  • SNSE’s TA Score: 2 bullish, 4 bearish.
  • VSTM’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VSTM is a better buy in the short-term than SNSE.

Price Growth

SNSE (@Biotechnology) experienced а -10.32% price change this week, while VSTM (@Biotechnology) price change was +14.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.93%. For the same industry, the average monthly price growth was +6.80%, and the average quarterly price growth was -5.97%.

Reported Earning Dates

SNSE is expected to report earnings on Jul 31, 2025.

VSTM is expected to report earnings on Aug 08, 2023.

Industries' Descriptions

@Biotechnology (+0.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($367M) has a higher market cap than SNSE($8.57M). VSTM YTD gains are higher at: 44.294 vs. SNSE (-27.280). SNSE has higher annual earnings (EBITDA): -28.38M vs. VSTM (-88.92M). VSTM has more cash in the bank: 113M vs. SNSE (47M). SNSE has less debt than VSTM: SNSE (4.47M) vs VSTM (41.4M). VSTM has higher revenues than SNSE: VSTM (10M) vs SNSE (0).
SNSEVSTMSNSE / VSTM
Capitalization8.57M367M2%
EBITDA-28.38M-88.92M32%
Gain YTD-27.28044.294-62%
P/E RatioN/AN/A-
Revenue010M-
Total Cash47M113M42%
Total Debt4.47M41.4M11%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNSEVSTM
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 20 days ago
74%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGEYX26.70N/A
N/A
GuideStone Funds Growth Equity Instl
TVRAX16.41N/A
N/A
NAA Allocation Fund A
CSPIX15.02N/A
N/A
Calvert Global Small-Cap Equity I
JRSNX11.67N/A
N/A
JH Adaptive Risk Mgd U.S. Eq N
ITCTX28.39N/A
N/A
VY® T. Rowe Price Capital Apprec S2

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
-1.76%
VSTM - SNSE
46%
Loosely correlated
+2.33%
GRI - SNSE
40%
Loosely correlated
-3.87%
ALZN - SNSE
40%
Loosely correlated
-18.83%
FATE - SNSE
36%
Loosely correlated
-6.54%
INAB - SNSE
33%
Loosely correlated
-1.84%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with GNLX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then GNLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
+2.33%
GNLX - VSTM
48%
Loosely correlated
-10.79%
ZLDAF - VSTM
47%
Loosely correlated
N/A
SNSE - VSTM
46%
Loosely correlated
-1.76%
HOOK - VSTM
40%
Loosely correlated
+2.24%
TGTX - VSTM
38%
Loosely correlated
-4.63%
More